IL137791A0 - Hapten-modified tumor cell membranes and their use - Google Patents

Hapten-modified tumor cell membranes and their use

Info

Publication number
IL137791A0
IL137791A0 IL13779199A IL13779199A IL137791A0 IL 137791 A0 IL137791 A0 IL 137791A0 IL 13779199 A IL13779199 A IL 13779199A IL 13779199 A IL13779199 A IL 13779199A IL 137791 A0 IL137791 A0 IL 137791A0
Authority
IL
Israel
Prior art keywords
hapten
tumor cell
cell membranes
modified tumor
modified
Prior art date
Application number
IL13779199A
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of IL137791A0 publication Critical patent/IL137791A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13779199A 1998-02-17 1999-02-17 Hapten-modified tumor cell membranes and their use IL137791A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2501298A 1998-02-17 1998-02-17
PCT/US1999/003536 WO1999040925A2 (en) 1998-02-17 1999-02-17 Hapten-modified tumor cell membranes and their use

Publications (1)

Publication Number Publication Date
IL137791A0 true IL137791A0 (en) 2001-10-31

Family

ID=21823570

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13779199A IL137791A0 (en) 1998-02-17 1999-02-17 Hapten-modified tumor cell membranes and their use

Country Status (12)

Country Link
EP (1) EP1054690A2 (en)
JP (1) JP2002502880A (en)
KR (1) KR20010041018A (en)
CN (1) CN1291105A (en)
AR (1) AR015237A1 (en)
AU (1) AU2686999A (en)
BR (1) BR9907912A (en)
CA (1) CA2320969A1 (en)
IL (1) IL137791A0 (en)
PL (1) PL342856A1 (en)
WO (1) WO1999040925A2 (en)
ZA (1) ZA991245B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366240A1 (en) * 1998-04-09 2005-01-24 Thomas Jefferson University A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
US6248585B1 (en) 1998-11-19 2001-06-19 Thomas Jefferson University Compositions for preserving haptenized tumor cells for use in vaccines
US7297330B2 (en) 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
JP2004507446A (en) * 2000-02-04 2004-03-11 トーマス・ジェファーソン・ユニバーシティ Immunotherapy of low-dose haptenized tumor cells and tumor cell extracts
US7612251B2 (en) 2000-09-26 2009-11-03 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
AU2003243485A1 (en) * 2002-06-10 2003-12-22 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
US11214603B2 (en) 2016-04-27 2022-01-04 The Regents Of The University Of Michigan C3D cellular and acellular vaccines for the prevention and treatment of cancer
CN115137814A (en) * 2022-07-01 2022-10-04 可蓝赛生物医药(上海)有限公司 Tumor vaccine adjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
JPH11507633A (en) * 1995-06-07 1999-07-06 トーマス・ジェファーソン・ユニバーシティ Hapten-modified tumor cell extracts and methods for treating or screening for cancer

Also Published As

Publication number Publication date
BR9907912A (en) 2000-10-24
PL342856A1 (en) 2001-07-16
EP1054690A2 (en) 2000-11-29
JP2002502880A (en) 2002-01-29
WO1999040925A2 (en) 1999-08-19
CN1291105A (en) 2001-04-11
AR015237A1 (en) 2001-04-18
CA2320969A1 (en) 1999-08-19
ZA991245B (en) 1999-08-18
KR20010041018A (en) 2001-05-15
WO1999040925A3 (en) 1999-10-21
AU2686999A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
IL143529A0 (en) An electrolysis cell and methods utilizing the same
HK1043876A1 (en) Solid gel membrane
PL342579A1 (en) Anchoring sheet and anchoring sheet module
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
ZA991346B (en) Air filtration arrangements and methods.
HUP0104825A3 (en) Genes and proteins, and their use
GB2352523B (en) Fluid-gauging systems and methods
IL137791A0 (en) Hapten-modified tumor cell membranes and their use
GB9821706D0 (en) Membrane structure
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB9818712D0 (en) In pond multi-skimmer
GB9911207D0 (en) Polymers and their use
GB9615900D0 (en) Improvements in diaphragms
GB9705744D0 (en) Methods for selecting cells and their uses
HUP0201022A2 (en) Outer surface proteins, their genes, and their use
GB9807586D0 (en) Enzymes and their use
HK1005963A1 (en) Galvanic cell
GB9807703D0 (en) Dewaterig membrane structure
GB9929581D0 (en) Comjpositions and their use
HUP0201800A2 (en) Novel calpains and their use
GB9923626D0 (en) Novel porous element and use thereof
GB9816014D0 (en) Piperidinecarboxamides and their use
HUP0105189A3 (en) Organoprotective solutions and their use